-
Infinity Pharmaceutical (INFI) Should Be Up at Least 50% Following AbbVie (ABBV) Agreement, Says RBC Capital
-
Unusual 11 Mid-Day Movers 11/21: (MEMS) (STV) (MDGN) Higher; (ZLC) (SCHL) (TLYS) Lower
-
Notable Analyst Rating Changes 11/21: (PENN) (THOR) (SKX) Upgraded; (HTWR) (EV) (ICA) Downgraded
-
RBC Capital Starts Infinity Pharmaceutical (INFI) at Outperform

